Patents by Inventor Markus Ferrari
Markus Ferrari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170189184Abstract: The invention relates to a catheter for the transvasculur implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) riming the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.Type: ApplicationFiled: March 21, 2017Publication date: July 6, 2017Applicant: JENAVALVE TECHNOLOGY, INC.Inventors: Rüdiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Publication number: 20160374803Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: June 28, 2016Publication date: December 29, 2016Applicant: JenaValve Technology, Inc.Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Publication number: 20160296326Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: ApplicationFiled: April 14, 2016Publication date: October 13, 2016Applicant: JenaValve Technology, Inc.Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
-
Patent number: 9402717Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: May 11, 2015Date of Patent: August 2, 2016Assignee: JenaValve Technology, Inc.Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 9339386Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has at plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: February 6, 2014Date of Patent: May 17, 2016Assignee: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Publication number: 20150342731Abstract: A device for the tranavascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (2) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: May 11, 2015Publication date: December 3, 2015Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 9044320Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: September 6, 2013Date of Patent: June 2, 2015Assignee: JenaValve Technology GmbHInventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 8932246Abstract: The present invention relates to a device for circulating a body fluid in a body of a living organism, especially to support the heart and/or circulation of the living organism, comprising a catheter device which has at least one inlet portion to take up the body fluid at at least one first location within the body of the living organism, at least one outlet portion some distance from the at least one inlet portion to discharge the body fluid at at least one second location some distance from the at least one first location within the body of the living organism and a pump device for directed transport of the body fluid between the at least one inlet portion and the at least one outlet portion of the catheter device; and a valve arrangement coupled to the catheter device for controlled uptake of the body fluid as a function of operation of the pump device at the at least one inlet portion of the catheter device and controlled discharge of the body fluid at the at least one outlet portion of the catheter devicType: GrantFiled: March 15, 2013Date of Patent: January 13, 2015Assignee: NovaPump GmbHInventor: Markus Ferrari
-
Publication number: 20140275720Abstract: So as to be able to determine the position of a functional element as precisely as possible during the invasive use of a blood pump in a patient's body without the use of imaging methods, the blood pump is connected to a main sensor which records signals of the patient's heart, which are compared to other electrophysiological heart signals recorded by several sensors distributed on the body surface so as to allow the position of the blood pump to be determined by way of linking.Type: ApplicationFiled: September 4, 2012Publication date: September 18, 2014Inventor: Markus Ferrari
-
Patent number: 8834561Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stunt is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: November 22, 2013Date of Patent: September 16, 2014Assignee: JenaValve Technology GmbHInventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20140222143Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has at plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: ApplicationFiled: February 6, 2014Publication date: August 7, 2014Applicant: JenaValve Technology GmbHInventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
-
Publication number: 20140214153Abstract: A catheter is disclosed for the transvascular implantation of prosthetic heart valves, e.g., including self-expanding anchorage supports, to reduce the risk to the patient during the implantation. Accordingly, a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which comprises a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.Type: ApplicationFiled: January 30, 2014Publication date: July 31, 2014Applicant: JENAVALVE TECHNOLOGY GMBHInventors: Rüdiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Publication number: 20140200663Abstract: The present invention relates to a medical apparatus for the therapeutic treatment of an insufficient cardiac valve (3a, 3b). The aim of the present invention is to specify a medical apparatus which enables the therapeutic treatment of an insufficient cardiac valve, such as, for example, the mitral valve (3a) or the tricuspid valve (3b), which is arranged between a ventricle (1a, 1b) and an atrium (2a, 2b) of the heart, in a manner as simple as possible and as gentle as possible for the patient in a minimally invasive intervention. For this purpose, the medical apparatus according to the present invention comprises at least one valve means (10) which is designed to prevent in the implanted condition of the medical apparatus a systolic venous reflex return of blood from the atrium (2a, 2b) of the heart into at least one vein (4a, 4a?, 4b, 4b?, 4c, 4c?) which belongs to a venous system (4) which leads into the atrium (2a, 2b) of the heart.Type: ApplicationFiled: March 14, 2014Publication date: July 17, 2014Applicant: JenaValve Technology, Inc.Inventors: Markus FERRARI, Hans-Reiner FIGULLA
-
Patent number: 8758430Abstract: The present invention relates to a medical apparatus for the therapeutic treatment of an insufficient cardiac valve (3a, 3b). The aim of the present invention is to specify a medical apparatus which enables the therapeutic treatment of an insufficient cardiac valve, such as, for example, the mitral valve (3a) or the tricuspid valve (3b), which is arranged between a ventricle (1a, 1b) and an atrium (2a, 2b) of the heart, in a manner as simple as possible and as gentle as possible for the patient in a minimally invasive intervention. For this purpose, the medical apparatus according to the present invention comprises at least one valve means (10) which is designed to prevent in the implanted condition of the medical apparatus a systolic venous reflex return of blood from the atrium (2a, 2b) of the heart into at least one vein (4a, 4a?, 4b, 4b?, 4c, 4c?) which belongs to a venous system (4) which leads into the atrium (2a, 2b) of the heart.Type: GrantFiled: January 23, 2009Date of Patent: June 24, 2014Assignee: JenaValve Technology, Inc.Inventors: Markus Ferrari, Hans-Reiner Figulla
-
Patent number: 8685085Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has at plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: February 18, 2011Date of Patent: April 1, 2014Assignee: JenaValve Technologies GmbHInventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Patent number: 8679174Abstract: A catheter for the transvascular implantation of prosthetic heart valves, including self-expanding anchorage supports, which allow a minimally invasive implantation of prosthetic heart valves to reduce the risk to the patient during the implantation. A prosthetic heart valve including anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which includes a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.Type: GrantFiled: January 12, 2006Date of Patent: March 25, 2014Assignee: JenaValve Technology, GmbHInventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20140081388Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stunt is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: November 22, 2013Publication date: March 20, 2014Applicant: JenaValve Technology, Inc.Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: RE45130Abstract: This invention relates to a device for fastening and anchoring heart valve prostheses which is essentially formed of wire-shaped interconnected elements. The aim of the invention is to be able to be implant, in a minimally invasive manner, a device of this type via the aorta by compressing the device to make it smaller, and by extending the same at the site of implantation, whereby ensuring a secure retention and a secure sealing with regard to the aorta wall. To this end, the invention provides that for fastening and supporting a cardiac valve prosthesis, three identical pairs of arched elements are interconnected, with a configuration that is offset by 120°, by means of solid body articulations. These solid body articulations carry out the function of pivot bearings.Type: GrantFiled: June 26, 2008Date of Patent: September 9, 2014Assignee: JenaValve Technology GmbHInventors: Hans-Reiner Figulla, Markus Ferrari, Carsten Weber, Thomas Peschel, Christoph Damm
-
Patent number: RE45790Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: August 7, 2014Date of Patent: November 3, 2015Assignee: JENAVALVE TECHNOLOGY GMBHInventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: RE45962Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: August 7, 2014Date of Patent: April 5, 2016Assignee: JenaValve Technology GmbHInventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm